Pfizer said on Tuesday its chief scientific officer Mikael Dolsten, a key figure behind the development of the company's COVID-19 vaccine, would step down after a more than 15-year career at the drugm
Pfizer (PFE) concluded the recent trading session at $27.93, signifying a -0.43% move from its prior day's close.

Bullish on Pfizer (PFE)

11:31am, Monday, 08'th Jul 2024
Pfizer (PFE) is today's morning trade for beginner, intermediate, and advanced options traders. Alan Knuckman demonstrates an example trade using PFE.
Pfizer's respiratory syncytial virus (RSV) vaccine for pregnant women was not tied to a higher risk of pre-term or early births, according to a study published on Monday that analyzed real-world use o

Pfizer: The Inflection Point Is Here

10:53am, Monday, 08'th Jul 2024
Pfizer's recent financial performance and Wall Street analysts' expectations around the upcoming quarterly earnings release suggest that we are currently at an inflection point. The company's current
Much of Pfizer's revenue is driven by therapies with only modest competition. This stock is also developing a very impressive dividend-growth track record.
Despite a tanking stock price, Pfizer has raised its dividend for 15 consecutive years. Pfizer's profits are off their peak but more than sufficient to continue raising the dividend.
Pfizer's been raising its dividend payout for 15 years, and a heap of new products could help it continue the streak. The largest publicly traded business development company, Ares Capital offers inve
Despite their recent struggles, these three industry giants hold the promise of significant upside. With favorable consensus price targets and ratings, attractive P/E valuations, solid earnings growth
24/7 Insights Wounded blue chip stocks can offer huge total return potential.
Real estate investment trust Agree Realty isn't nearly as risky as it seems with just a superficial glance. Pharmaceutical giant Pfizer isn't the powerhouse it used to be, but what it lacks in firepow
First half of 2024 is profitable for investors, S&P 500 up 14.48% and Dividend Harvesting Portfolio ROI at 14.05%. Market outlook positive with Fed rate cuts expected, unemployment increase may signal
Today, we will discuss juicy long-term dividend growth stocks that have grown for over a decade. It's fairly easy to find stocks that have continuously grown dividends over the past decade.
Pfizer (PFE) expects its operational revenues to improve, driven by its in-line products like Vyndaqel, new launches like Abrysvo and newly acquired products, including those acquired from Seagen.
When it rains, it pours. However, the storm will eventually pass.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE